Results 101 to 110 of about 37,820 (304)

Dupilumab for bullous pemphigoid with intractable pruritus [PDF]

, 2019
Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. Treatment regimens typically include topical and systemic immunosuppressive medications.
Eichenfield, Dawn Z, Orme, Charisse M, Seidman, Jason S   +2 more
core  

MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA [PDF]

Chest, 2020
Q. Shahzad, M. Zaheer
openaire   +1 more source

Respiratory Syncytial Virus Under the Lens of Structure: From Prefusion Stabilization to Next‐Generation Immunotherapies

iNew Medicine, EarlyView.
This illustration integrates key concepts covered in the review, including high‐risk populations, viral structure, host entry factors, the replication cycle, and licensed antibody‐based prevention strategies. ABSTRACT Respiratory syncytial virus (RSV) is a negative‐sense RNA virus belonging to the genus Orthopneumovirus within the family Pneumoviridae.
Zekai Cheng, Qianqian Wang, Jiachen Zhang, Sandra Chiu   +3 more
wiley   +1 more source

Severe Asthma—Perspectives From Adult and Pediatric Pulmonology

Frontiers in Pediatrics, 2019
Both adults and children with severe asthma represent a small proportion of the asthma population; however, they consume disproportionate resources. For both groups it is important to confirm the diagnosis of severe asthma and ensure that modifiable ...
Louise Fleming, Liam Heaney
doaj   +1 more source

Bronchoscopy, Imaging, and Concurrent Diseases in Dogs with Bronchiectasis: (2003-2014). [PDF]

, 2015
BackgroundBronchiectasis is a permanent and debilitating sequel to chronic or severe airway injury, however, diseases associated with this condition are poorly defined.ObjectiveTo evaluate results of diagnostic tests used to document bronchiectasis and ...
Byrne, BA, Johnson, EG, Johnson, LR, Kass, PH, Vernau, W   +4 more
core   +1 more source

Benchmarking Hybrid CNN‐Transformer Versus Pure Transformer Architectures for Accelerated Hyperpolarized 129Xe MRI Reconstruction

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Hyperpolarized 129Xe MRI faces technical challenges including low signal‐to‐noise ratio and breath‐hold constraints. Current literature focuses on proprietary deep learning methods or image‐domain enhancements. Purpose To present a comprehensive evaluation of transformer and hybrid CNN‐transformer architectures integrating dual ...
Ramtin Babaeipour, Matthew S. Fox, Grace Parraga, Alexei Ouriadov   +3 more
wiley   +1 more source

Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial

ERJ Open Research
Background Severe asthma affects the working life of millions of people worldwide. Interleukin (IL)-5/anti-interleukin-5 receptor α (IL-5Rα) antibodies are highly effective in reducing symptoms in patients with severe eosinophilic asthma.
Lina Brinkmann, Jan Fuge, Tobias Welte, Hendrik Suhling, Nora Drick   +4 more
doaj   +1 more source

Level of Eosinophil Cationic Protein in Sputum of Chemical Warfare Victims [PDF]

Objective(s) Considering fair response to inhaled corticosteroids and reports of severe air way hyper responsiveness in chemical warfare victims (CWV), a role for eosinophilic inflammation (i.e. asthma) was postulated.
توحیدی, محمد, جعفريان, امير حسين, خاكزاد, محمد رضا, خواجه دلوئی, محمد, عطاران, داود, قبادی مراللو, حسن, محمدزاده لاری, شهرزاد, مير صدرائی, مجيد   +7 more
core  

Histopathologic parameters as predictors of response to endoscopic sinus surgery in nonallergic patients with chronic rhinosinusitis [PDF]

, 2006
OBJECTIVE: To estimate the predictable value of histopathologic parameters in chronic rhinosinusitis (CRS) for response to endoscopic sinus surgery (ESS).
Bhattacharyya N., Damm M, Dhong HJ, Drvi P, Dunlop G, Kaliner MA, Kalogjera L, Lavigne F, Marks SC, Watelet JB   +9 more
core   +1 more source

Mepolizumab, quality of life, and severe eosinophilic asthma [PDF]

The Lancet Respiratory Medicine, 2017
It is now ten years since the publication of the first clinical trial, eight years since the first key proof of concept studies in a population selected on the basis of inflammatory pattern and two years since approval of Mepolizumab as a treatment for severe eosinophilic asthma.
openaire   +3 more sources